Selection of recombinant anti-SH3 domain antibodies by high-throughput phage display

Protein Science

Volumn , Issue , 2015, Pages 1890-1900

  Huang, Haiming ^a,b   Economopoulos, Nicolas O ^a,b   Liu, Bernard A ^a,c   Uetrecht, Andrea ^a   Gu, Jun ^a,b   Jarvik, Nick ^a   Nadeem, Vincent ^a,b   Pawson, Tony ^a,c   Moffat, Jason ^a   Miersch, Shane ^a,b   Sidhu, Sachdev S ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

antibodies; high throughput method; phage display; SH3 domain

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; PROTEIN SH3; RECOMBINANT ANTIBODY;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOLOGY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TARGETING;

EID: 84973595875     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2799     Document Type: Article

References (50)

1. Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497.
2. Dubel S, Stoevesandt O, Taussig MJ, Hust M (2010) Generating recombinant antibodies to the complete human proteome. Trends Biotechnol 28:333–339.
3. Sidhu SS (2012) Antibodies for all: the case for genome-wide affinity reagents. FEBS Lett 586:2778–2779.
4. Bradbury AR, Sidhu S, Dubel S, McCafferty J (2011) Beyond natural antibodies: the power of in vitro display technologies. Nat Biotechnol 29:245–254.
5. McCafferty J, Griffiths AD, Winter G, Chiswell DJ (1990) Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348:552–554.
6. Clackson T, Hoogenboom HR, Griffiths AD, Winter G (1991) Making antibody fragments using phage display libraries. Nature 352:624–628.
7. Winter G, Milstein C (1991) Man-made antibodies. Nature 349:293–299.
8. Altshuler EP, Serebryanaya DV, Katrukha AG (2010) Generation of recombinant antibodies and means for increasing their affinity. Biochemistry 75:1584–1605.
9. Barbas CF3, Kang AS, Lerner RA, Benkovic SJ (1991) Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA 88:7978–7982.
10. Lee CV, Hymowitz SG, Wallweber HJ, Gordon NC, Billeci KL, Tsai SP, Compaan DM, Yin J, Gong Q, Kelley RF, DeForge LE, Martin F, Starovasnik MA, Fuh G. (2006) Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells. Blood 108:3103–3111.
11. Strachan G, McElhiney J, Drever MR, McIntosh F, Lawton LA, Porter AJ (2002) Rapid selection of anti-hapten antibodies isolated from synthetic and semi-synthetic antibody phage display libraries expressed in Escherichia coli. FEMS Microbiol Lett 210:257–261.
12. Gargir A, Ofek I, Meron-Sudai S, Tanamy MG, Kabouridis PS, Nissim A (2002) Single chain antibodies specific for fatty acids derived from a semi-synthetic phage display library. Biochim Biophys Acta 1569:167–173.
13. Ye JD, Tereshko V, Frederiksen JK, Koide A, Fellouse FA, Sidhu SS, Koide S, Kossiakoff AA, Piccirilli JA (2008) Synthetic antibodies for specific recognition and crystallization of structured RNA. Proc Natl Acad Sci USA 105:82–87.
14. Huang H, Sidhu SS (2011) Studying binding specificities of peptide recognition modules by high-throughput phage display selections. Methods Mol Biol 781:87–97.
15. Schofield DJ, Pope AR, Clementel V, Buckell J, Chapple S, Clarke KF, Conquer JS, Crofts AM, Crowther SR, Dyson MR, Flack G, Griffin GJ, Hooks Y, Howat WJ, Kolb-Kokocinski A, Kunze S, Martin CD, Maslen GL, Mitchell JN, O'Sullivan M, Perera RL, Roake W, Shadbolt SP, Vincent KJ, Warford A, Wilson WE, Xie J, Young JL, McCafferty J (2007) Application of phage display to high throughput antibody generation and characterization. Genome Biol 8:R254
16. Frisch C, Brocks B, Ostendorp R, Hoess A, von Ruden T, Kretzschmar T (2003) From EST to IHC: human antibody pipeline for target research. J Immunol Methods 275:203–212.
17. Mersmann M, Meier D, Mersmann J, Helmsing S, Nilsson P, Graslund S, Colwill K, Hust M, Dubel S (2010) Towards proteome scale antibody selections using phage display. N Biotechnol 27:118–128.
18. Pershad K, Pavlovic JD, Graslund S, Nilsson P, Colwill K, Karatt-Vellatt A, Schofield DJ, Dyson MR, Pawson T, Kay BK, McCafferty J (2010) Generating a panel of highly specific antibodies to 20 human SH2 domains by phage display. Protein Eng Des Sel 23:279–288.
19. Terpe K (2003) Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 60:523–533.
20. Lichty JJ, Malecki JL, Agnew HD, Michelson-Horowitz DJ, Tan S (2005) Comparison of affinity tags for protein purification. Protein Expr Purif 41:98–105.
21. Mayer BJ (2001) SH3 domains: complexity in moderation. J Cell Sci 114:1253–1263.
22. Li SS (2005) Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem J 390:641–653.
23. Persson H, Ye W, Wernimont A, Adams JJ, Lam R, Sidhu SS (2013) CDR-H3 diversity is not required for antigen recognition by synthetic antibodies. J Mol Biol 425:803–811.
24. Lefranc MP, Pommie C, Ruiz M, Giudicelli V, Foulquier E, Truong L, Thouvenin-Contet V, Lefranc G (2003) IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol 27:55–77.
25. Fellouse FAS, Sidhu, SS, Making antibodies in bacteria. In: Howard GC, Kaser MR, Eds. (2007) Making and using anti-bodies, Boca Raton, FL: CRC Press, pp 157–180.
26. Kunkel TA, Roberts JD, Zakour RA (1987) Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol 154:367–382.
27. Huang D, Marshall DC, Hancock JF (1993) Plasma membrane-targeted ras GTPase-activating protein is a potent suppressor of p21ras function. Mol Cell Biol 13:2420–2431.
28. Sharma SV (1998) Rapid recruitment of p120RasGAP and its associated protein, p190RhoGAP, to the cytoskeleton during integrin mediated cell-substrate interaction. Oncogene 17:271–281.
29. Heger A, Holm L (2003) Exhaustive enumeration of protein domain families. J Mol Biol 328:749–767.
30. Copley RR, Doerks T, Letunic I, Bork P (2002) Protein domain analysis in the era of complete genomes. FEBS Lett 513:129–134.
31. Pawson T, Nash P (2003) Assembly of cell regulatory systems through protein interaction domains. Science 300:445–452.
32. Jadwin JA, Ogiue-Ikeda M, Machida K (2012) The application of modular protein domains in proteomics. FEBS Lett 586:2586–2596.
33. Chen G, Koellhoffer JF, Zak SE, Frei JC, Liu N, Long H, Ye W, Nagar K, Pan G, Chandran K, Dye JM, Sidhu SS, Lai JR (2014) Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge. ACS Chem Biol 9:2263–2273.
34. Gao J, Sidhu SS, Wells JA (2009) Two-state selection of conformation-specific antibodies. Proc Natl Acad Sci USA 106:3071–3076.
35. Couchman JR (2009) Commercial antibodies: the good, bad, and really ugly. J Histochem Cytochem 57:7–8.
36. Grimsey NL, Goodfellow CE, Scotter EL, Dowie MJ, Glass M, Graham ES (2008) Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!. J Neurosci Methods 171:78–86.
37. Jensen BC, Swigart PM, Simpson PC (2009) Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific. Naunyn Schmiedebergs Arch Pharmacol 379:409–412.
38. Michel MC, Wieland T, Tsujimoto G (2009) How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol 379:385–388.
39. Spicer SS, Spivey MA, Ito M, Schulte BA (1994) Some ascites monoclonal antibody preparations contain contaminants that bind to selected Golgi zones or mast cells. J Histochem Cytochem 42:213–221.
40. Marx V (2013) Calling the next generation of affinity reagents. Nat Methods 10:829–833.
41. Sidhu SS, Lowman HB, Cunningham BC, Wells JA (2000) Phage display for selection of novel binding peptides. Methods Enzymol 328:333–363.
42. Quevillon E, Silventoinen V, Pillai S, Harte N, Mulder N, Apweiler R, Lopez R (2005) InterProScan: protein domains identifier. Nucleic Acids Res 33:W116–W120.
43. Miersch S, Li Z, Hanna R, McLaughlin ME, Hornsby M, Matsuguchi T, Paduch M, Annika Sääf A, Wells J, Koide S, Kossiakoff A, Sidhu SS (2015) Scalable high throughput selection from phage-displayed synthetic antibody libraries. J Vis Exp e51492
44. Gough J, Karplus K, Hughey R, Chothia C (2001) Assignment of homology to genome sequences using a library of hidden Markov models that represent all proteins of known structure. J Mol Biol 313:903–919.
45. Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, Boursnell C, Pang N, Forslund K, Ceric G, Clements J, Heger A, Holm L, Sonnhammer EL, Eddy SR, Bateman A, Finn RD (2012) The Pfam protein families database. Nucleic Acids Res 40:D290–D301.
46. Letunic I, Doerks T, Bork P (2012) SMART 7: recent updates to the protein domain annotation resource. Nucleic Acids Res 40:D302–D305.
47. Hubbard T, Barker D, Birney E, Cameron G, Chen Y, Clark L, Cox T, Cuff J, Curwen V, Down T, Durbin R, Eyras E, Gilbert J, Hammond M, Huminiecki L, Kasprzyk A, Lehvaslaiho H, Lijnzaad P, Melsopp C, Mongin E, Pettett R, Pocock M, Potter S, Rust A, Schmidt E, Searle S, Slater G, Smith J, Spooner W, Stabenau A, Stalker J, Stupka E, Ureta-Vidal A, Vastrik I, Clamp M (2002) The Ensembl genome database project. Nucleic Acids Res 30:38–41.
48. Chen G, Sidhu SS (2014) Design and generation of synthetic antibody libraries for phage display. Methods Mol Biol 1131:113–131.
49. Koellhoffer JF, Chen G, Sandesara RG, Bale S, Saphire EO, Chandran K, Sidhu SS, Lai JR (2012) Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein. Chembiochem 13:2549–2557.
50. McCluskey AJ, Bolewska-Pedyczak E, Jarvik N, Chen G, Sidhu SS, Gariepy J (2012) Charged and hydrophobic surfaces on the a chain of shiga-like toxin 1 recognize the C-terminal domain of ribosomal stalk proteins. PLoS One 7:e31191